Nuheara (ASX:NUH) - Hisse Senedi Fiyatı, Haberler ve Analizler

NUH Stoklara Genel Bakış

A wearables technology company, engages in the development and commercialization of hearing technology and products as regulated medical devices in Australia, the United States, and internationally.

Şirket hakkında

NUH temel anali̇z
Kar Tanesi Skoru
Değerleme	0/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	0/6
Finansal Sağlık	3/6
Temettüler	0/6

Ödüller

Risk Analizi

Kazançlar son 5 yılda yılda 11.8% oranında azaldı

Hissedarlar geçen yıl önemli ölçüde sulandırıldı

Hisse senetleri oldukça likit değildir

Anlamlı bir geliri yok ( A$2M )

+ 2 daha fazla risk

Nuheara Limited Rakipler

BirdDog Technology

ASX:BDT

AU$10.5m

Zimi

ASX:ZMM

AU$4.9m

ASX:TZL

AU$19.2m

Ambertech

ASX:AMO

AU$15.7m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Nuheara
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	AU$0.081
52 Haftanın En Yüksek Seviyesi	AU$0.21
52 Haftanın En Düşük Seviyesi	AU$0.07
Beta	1.87
11 Aylık Değişim	0%
3 Aylık Değişim	3.85%
1 Yıllık Değişim	-42.14%
33 Yıllık Değişim	-90.36%
5 Yıllık Değişim	-94.53%
Halka arzdan bu yana değişim	-91.38%

Son Haberler & Güncellemeler

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Oct 09

Recent updates

Hissedar Getirileri

	NUH	AU Tech	AU Pazar
7D	0%	-2.5%	0.2%
1Y	-42.1%	19.2%	16.6%

Getiri vs. Endüstri: NUH geçen yıl % 19.2 oranında getiri sağlayan Australian Tech sektörünün gerisinde kaldı.

Getiri vs Piyasa: NUH geçen yıl % 16.6 oranında getiri sağlayan Australian Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is NUH's price volatile compared to industry and market?
NUH volatility
NUH Average Weekly Movement	n/a
Tech Industry Average Movement	6.4%
Market Average Movement	8.4%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.5%

İstikrarlı Hisse Senedi Fiyatı: NUH son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: NUH 'un son bir yıldaki oynaklık değişimini belirlemek için Yetersiz veri.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
n/a	n/a	Justin Miller	www.nuheara.com

Nuheara Limited Temel Bilgiler Özeti

Nuheara'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
NUH temel i̇stati̇sti̇kler
Piyasa değeri	AU$21.76m
Kazançlar(TTM)	-AU$12.62m
Gelir(TTM)	AU$1.93m

11.3x

P/S Oranı

-1.7x

F/K Oranı

NUH aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
NUH gelir tablosu (TTM)
Gelir	AU$1.93m
Gelir Maliyeti	AU$2.88m
Brüt Kâr	-AU$951.47k
Diğer Giderler	AU$11.67m
Kazançlar	-AU$12.62m

Son Raporlanan Kazançlar

Jun 30, 2023

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	-0.047
Brüt Marj	-49.27%
Net Kâr Marjı	-653.33%
Borç/Özkaynak Oranı	46.3%

NUH uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

NUH Stoklara Genel Bakış

Ödüller

Risk Analizi

Nuheara Limited Rakipler

ASX:BDT

AU$10.5m

ASX:ZMM

AU$4.9m

ASX:TZL

AU$19.2m

ASX:AMO

AU$15.7m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Recent updates

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Nuheara Limited, Annual General Meeting, Nov 22, 2023

New major risk - Financial position

Nuheara Limited Announces Appointment of Catherine Morgan as Head of Compliance, Regulatory and Legal

New minor risk - Share price stability

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million.

First half 2023 earnings released: AU$0.048 loss per share (vs AU$0.065 loss in 1H 2022)

Insufficient new directors

Nuheara Announces Commercial Availability of HP Hearing PRO OTC Hearing Aid

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.025401 million.

Nuheara Limited Receives US FDA Approval and Launches HP Hearing PRO

Nuheara Limited to Report Q1, 2023 Results on Oct 31, 2022

Nuheara Limited Announces the Resignation of Jean-Marie Rudd as CFO

Full year 2022 earnings released: AU$0.16 loss per share (vs AU$0.10 loss in FY 2021)

Nuheara Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.093 loss in FY 2021)

Nuheara Limited Welcomes US Food and Drug Administration's Final Ruling, Establishing A Regulatory Category for Over-The-Counter (Otc) Hearing Aids in the United States

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Limited Announces Executive Changes

Nuheara Limited has filed an IPO in the amount of AUD 5 million.

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Submits 510(k) for U.S. FDA Clearance

Nuheara Announces Executive Changes

Nuheara Limited Announces Successful Clinical Trial Self-Fitted Hearing Aids

Nuheara Limited to Report Q2, 2022 Results on Jan 31, 2022

Nuheara Clinical Trial and FDA 510(K) Pathway Update

We Think Nuheara (ASX:NUH) Needs To Drive Business Growth Carefully

Nuheara Limited Provides Update on Clinical Trial and Pathway to FDA 510(K) Approval

Is Nuheara (ASX:NUH) In A Good Position To Deliver On Growth Plans?

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.011 loss in FY 2020)

Nuheara Limited Receives U.S. FDA Registration and Hearing Aid Device Listing

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in 1H 2020)

What Can We Make Of Nuheara's (ASX:NUH) CEO Compensation?

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 11.5 million.

Nuheara Limited announced that it expects to receive AUD 11.5 million in funding

Nuheara Limited Appoints Warwick Sauer as Director

Is Nuheara (ASX:NUH) Using Debt In A Risky Way?

Nuheara Receives $2 Million Phase II Works with HP Inc

Full year earnings released - AU$0.011 loss per share

Nuheara Limited announced that it has received funding

Hissedar Getirileri

Fiyat Oynaklığı

Şirket Hakkında

Nuheara Limited Temel Bilgiler Özeti

11.3x

-1.7x

Kazanç ve Gelir